• Privacy Policy
  • Terms Of Service
  • Facebook
  • Twitter
  • LinkedIn
  • Instagram
Forex trading, free forex education | Forex.ca

 

  • Home
  • Forex News
  • Stock News
  • For Beginners
  • Market Analysis
  • Trading Strategies
  • Real Time Stock Update
  • Shop
News Ticker
  • [ April 7, 2026 ] Iran: Deal Or No Deal? The Citrini Report And EU Diplomacy Suggest One May Happen Stock News
  • [ April 7, 2026 ] Cardiff Oncology: Market Dismisses Onvansertib's Potential In First-Line Colorectal Cancer Stock News
  • [ April 6, 2026 ] Tesla: Weak Start To 2026 Stock News
  • [ April 6, 2026 ] XPEL Is On A Great Trip, But That Doesn't Mean It's Right To Join In Stock News
  • [ April 5, 2026 ] Buy 7 S&P 500 April Dividend Dogs Stock News
Home2022

Year: 2022

Stock News

RYLD And XYLD: 2 High Income Choices

May 23, 2022 admin 0

imagedepotpro/E+ via Getty Images Today, we will cover two popular funds from the Global X family. Both funds are rather similar in structure and scope and only differ in terms of which index they use […]

Stock News

Monthly REIT Mailbox Mojo | Seeking Alpha

May 23, 2022 admin 0

Kameleon007/E+ via Getty Images It’s that time again: time for a monthly dividend-paying real estate investment trust (“REIT”) article. Admittedly, it’s only been a month or so since the last writeup I published about them. […]

Stock News

Bunge Stock Correction: A Buying Opportunity (NYSE:BG)

May 23, 2022 admin 0

SimonSkafar/E+ via Getty Images Fuel and food prices have exploded higher, which is bad news for consumers. The companies that feed the world are experiencing rising input prices, but profits are rising. The ABCD companies […]

Posts navigation

« 1 … 20,996 20,997 20,998 … 25,381 »

For Beginners


Categories

  • Forex News
  • Stock News
No Picture
Stock News

Iran: Deal Or No Deal? The Citrini Report And EU Diplomacy Suggest One May Happen

April 7, 2026 0

Iran: Deal Or No Deal? The Citrini Report And EU Diplomacy Suggest One May Happen

No Picture
Stock News

Cardiff Oncology: Market Dismisses Onvansertib's Potential In First-Line Colorectal Cancer

April 7, 2026 0

Cardiff Oncology: Market Dismisses Onvansertib's Potential In First-Line Colorectal Cancer

Latest news
  • Analytical US Natural Gas Price Forecast: Outlook 2026–2030
    March 20, 2026 0
  • Nvidia (NVDA) Shares Surpass $200 in After-Hours Trading Following Earnings Report
    February 26, 2026 0
Random News
  • Pegasystems Inc. (PEGA) Q3 2022 Earnings Call Transcript
    October 27, 2022 0
  • Market Tailwinds Turning Into Headwinds
    November 7, 2022 0
  • Comcast Stock: After A 40% Rally, Is It Time To Lock In Gains? (NASDAQ:CMCSA)
    January 26, 2023 0
Email Inquiries to: warp1@sympatico.ca
  • No Picture
    Iran: Deal Or No Deal? The Citrini Report And EU Diplomacy Suggest One May Happen
    April 7, 2026 0
  • No Picture
    Cardiff Oncology: Market Dismisses Onvansertib's Potential In First-Line Colorectal Cancer
    April 7, 2026 0
Pages
  • Contact Us
  • Home
  • Privacy Policy
  • Real Time Stock Update
  • Shop
  • Terms Of Service

© Copyright 2020-2023 Forex.ca

Please note that foreign exchange and other leveraged trading involves significant risk of loss. It is not suitable for all investors and you should make sure you understand the risks involved, seeking independent advice if necessary.